These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
751 related articles for article (PubMed ID: 9364988)
1. Selection of S18326 as a new potent and selective boronic acid direct thrombin inhibitor. Rupin A; Mennecier P; Lila C; de Nanteuil G; Verbeuren TJ Thromb Haemost; 1997 Oct; 78(4):1221-7. PubMed ID: 9364988 [TBL] [Abstract][Full Text] [Related]
2. In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design. Costanzo MJ; Almond HR; Hecker LR; Schott MR; Yabut SC; Zhang HC; Andrade-Gordon P; Corcoran TW; Giardino EC; Kauffman JA; Lewis JM; de Garavilla L; Haertlein BJ; Maryanoff BE J Med Chem; 2005 Mar; 48(6):1984-2008. PubMed ID: 15771442 [TBL] [Abstract][Full Text] [Related]
3. Profiling the structural determinants for the selectivity of representative factor-Xa and thrombin inhibitors using combined ligand-based and structure-based approaches. Bhunia SS; Roy KK; Saxena AK J Chem Inf Model; 2011 Aug; 51(8):1966-85. PubMed ID: 21761917 [TBL] [Abstract][Full Text] [Related]
4. Development of plasma kallikrein selective inhibitors. Okada Y; Tsuda Y; Tada M; Wanaka K; Hijikata-Okunomiya A; Okamoto U; Okamoto S Biopolymers; 1999; 51(1):41-50. PubMed ID: 10380351 [TBL] [Abstract][Full Text] [Related]
5. In vivo characterization of a new synthetic thrombin inhibitor. Knabb RM; Kettner CA; Timmermans PB; Reilly TM Thromb Haemost; 1992 Jan; 67(1):56-9. PubMed ID: 1615483 [TBL] [Abstract][Full Text] [Related]
6. The selective inhibition of thrombin by peptides of boroarginine. Kettner C; Mersinger L; Knabb R J Biol Chem; 1990 Oct; 265(30):18289-97. PubMed ID: 2211702 [TBL] [Abstract][Full Text] [Related]
7. A family of arginal thrombin inhibitors related to efegatran. Smith GF; Shuman RT; Craft TJ; Gifford DS; Kurz KD; Jones ND; Chirgadze N; Hermann RB; Coffman WJ; Sandusky GE; Roberts E; Jackson CV Semin Thromb Hemost; 1996; 22(2):173-83. PubMed ID: 8807715 [TBL] [Abstract][Full Text] [Related]
8. Inhibitory properties of a novel human Kunitz-type protease inhibitor homologous to tissue factor pathway inhibitor. Petersen LC; Sprecher CA; Foster DC; Blumberg H; Hamamoto T; Kisiel W Biochemistry; 1996 Jan; 35(1):266-72. PubMed ID: 8555184 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of urokinase by 4-substituted benzo[b]thiophene-2-carboxamidines: an important new class of selective synthetic urokinase inhibitor. Towle MJ; Lee A; Maduakor EC; Schwartz CE; Bridges AJ; Littlefield BA Cancer Res; 1993 Jun; 53(11):2553-9. PubMed ID: 8495419 [TBL] [Abstract][Full Text] [Related]
10. Effects of tannins from Geum japonicum on the catalytic activity of thrombin and factor Xa of blood coagulation cascade. Dong H; Chen SX; Kini RM; Xu HX J Nat Prod; 1998 Nov; 61(11):1356-60. PubMed ID: 9834152 [TBL] [Abstract][Full Text] [Related]
11. Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation. Gresele P; Momi S; Berrettini M; Nenci GG; Schwarz HP; Semeraro N; Colucci M J Clin Invest; 1998 Feb; 101(3):667-76. PubMed ID: 9449701 [TBL] [Abstract][Full Text] [Related]
12. Antithrombotic and anticoagulant profiles of TAK-442, a novel factor Xa inhibitor, in a rabbit model of venous thrombosis. Kawamura M; Konishi N; Hiroe K; Shofuda K; Imaeda Y; Fujimoto T; Kubo K J Cardiovasc Pharmacol; 2010 Aug; 56(2):156-61. PubMed ID: 20410831 [TBL] [Abstract][Full Text] [Related]
13. Structure-based design of residue 1 analogs of the direct thrombin inhibitor pentapeptide FM 19. Girnys EA; Sobczyk-Kojiro K; Mosberg HI Chem Biol Drug Des; 2010 Jan; 75(1):35-9. PubMed ID: 19954432 [TBL] [Abstract][Full Text] [Related]
14. Aqueous extract from Brownea grandiceps flowers with effect on coagulation and fibrinolytic system. Pereira B; Brazón J J Ethnopharmacol; 2015 Feb; 160():6-13. PubMed ID: 25460592 [TBL] [Abstract][Full Text] [Related]
15. Ultrasensitive fluorogenic substrates for serine proteases. Butenas S; DiLorenzo ME; Mann KG Thromb Haemost; 1997 Oct; 78(4):1193-201. PubMed ID: 9364984 [TBL] [Abstract][Full Text] [Related]
16. Design and characterization of dipetacompinR10H, a dipetalogastin II-derived, classical competitive thrombin inhibitor. Bitter T; López M; Nowak G Thromb Haemost; 2007 Jan; 97(1):139-45. PubMed ID: 17200781 [TBL] [Abstract][Full Text] [Related]
17. Highly potent and selective substrate analogue factor Xa inhibitors containing D-homophenylalanine analogues as P3 residue: part 2. Stürzebecher A; Dönnecke D; Schweinitz A; Schuster O; Steinmetzer P; Stürzebecher U; Kotthaus J; Clement B; Stürzebecher J; Steinmetzer T ChemMedChem; 2007 Jul; 2(7):1043-53. PubMed ID: 17541992 [TBL] [Abstract][Full Text] [Related]